Tumor necrosis factor-a suppresses the ventilatory hypoxic response via nitric oxide dependent pathways. Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001
Interleukin-4, tumor necrosis factor-alpha and ECP in serum and sputum: comparison between normal and allergic asthmatics children Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003
Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients Source: Eur Respir J 2007; 30: 701-707 Year: 2007
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Mast cell-derived tumour necrosis factor is essential for allergic airway disease Source: Eur Respir J 2008; 31: 773-782 Year: 2008
A major inflammatory cytokine TNF-a inhibits the ventilatory response to hypoxia Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018
Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005
Tumour necrosis factor-α polymorphism and ozone-induced lung function change Source: Annual Congress 2003 - Effects of outdoor air pollution in adults Year: 2003
The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis Year: 2004
Primary and secondary necrosis as local determinants of LPS-induced airway inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 587s Year: 2003
Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006
Does tumor necrosis factor-α (TNFα) protect immune cells from apoptosis in lower airways? Source: Eur Respir J 2007; 30: Suppl. 51, 111s Year: 2007
Effects of zinc on the interleukin-1 and tumor necrosis factor in experimental silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 517s Year: 2002
Ketotifen induces primary necrosis in eosinophils Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease in vitro Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
The inhibition of amiloride-sensitive current by tumor necrosis factor-alpha in alveolar type II epithelial cells and its signalling mechanism Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003
Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001